Glycemic variability and mortality in patients with aortic diseases: A multicenter retrospective cohort study

血糖波动与主动脉疾病患者死亡率:一项多中心回顾性队列研究

阅读:2

Abstract

BACKGROUND: The influence of glycemic variability (GV), defined as blood glucose fluctuations, on short-term mortality in patients with aortic diseases, such as aneurysms and dissections, remains understudied. This study evaluates the association between GV and mortality, explores non-linear patterns, and determines a GV threshold predictive of mortality risk. METHODS: A retrospective analysis of 2,441 patients with aortic aneurysm or dissection from the MIMIC IV and eICU-CRD databases was performed. Key variables, including demographics, clinical characteristics, comorbidities, laboratory findings, and treatments, were assessed. Logistic and Cox regression models, smooth curve fitting, and subgroup analyses examined associations between GV and ICU and 30-day mortality. RESULTS: ICU mortality occurred in 165 patients (6.8%), and 30-day mortality in 235 patients (9.6%). Increased GV was linearly associated with ICU mortality risk (P for non-linearity = 0.666). For 30-day mortality, a U-shaped relationship was observed, with minimal risk at a GV index of 0.2047 (P for non-linearity = 0.041). Adjusted models confirmed these findings (ICU mortality: OR = 1.15, 95% CI = 1.03-1.30, 30-day mortality: HR = 1.10, 95% CI = 1.03-1.18). CONCLUSIONS: GV is significantly associated with short-term mortality in aortic disease patients, with a U-shaped pattern for 30-day mortality and an optimal threshold of 0.2047. These findings underscore the importance of tailored glucose management strategies and call for further research into underlying mechanisms.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。